-
Something wrong with this record ?
The effects of nano-sized PbO on biomarkers of membrane disruption and DNA damage in a sub-chronic inhalation study on mice
L. Bláhová, Z. Nováková, Z. Večeřa, L. Vrlíková, B. Dočekal, J. Dumková, K. Křůmal, P. Mikuška, M. Buchtová, A. Hampl, K. Hilscherová, L. Bláha,
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Biomarkers metabolism MeSH
- Inhalation Exposure adverse effects analysis MeSH
- Liver drug effects metabolism MeSH
- Kidney drug effects metabolism MeSH
- Humans MeSH
- Membrane Lipids metabolism MeSH
- Brain drug effects metabolism MeSH
- Mice, Inbred ICR MeSH
- Mice MeSH
- Nanoparticles metabolism toxicity MeSH
- Lead metabolism toxicity MeSH
- Oxidation-Reduction MeSH
- Oxidative Stress drug effects MeSH
- Oxides metabolism toxicity MeSH
- Lipid Peroxidation drug effects MeSH
- Lung drug effects metabolism MeSH
- DNA Damage * MeSH
- Toxicity Tests, Subchronic MeSH
- Inflammation MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Although the production of engineered nanoparticles increases our knowledge of toxicity and mechanisms of bioactivity during relevant exposures is lacking. In the present study mice were exposed to PbO nanoparticles (PbONP; 192.5 µg/m3; 1.93 × 106 particles/cm3) for 2, 5 and 13 weeks through continuous inhalation. The analyses addressed Pb and PbONP distribution in organs (lung, liver, kidney, brain) using electrothermal atomic absorption spectrometry and transmission electron microscopy, as well as histopathology and analyses of oxidative stress biomarkers. New LC-MS/MS methods were validated for biomarkers of lipid damage F2-isoprostanes (8-iso-prostaglandins F2-alpha and E2) and hydroxylated deoxoguanosine (8-OHdG, marker of DNA oxidation). Commonly studied malondialdehyde was also measured as TBARS by HPLC-DAD. The study revealed fast blood transport and distribution of Pb from the lung to the kidney and liver. A different Pb accumulation trend was observed in the brain, suggesting transfer of NP along the nasal nerve to the olfactory bulbs. Long-term inhalation of PbONP caused lipid peroxidation in animal brains (increased levels of TBARS and both isoprostanes). Membrane lipid damage was also detected in the kidney after shorter exposures, but not in the liver or lung. On the contrary, longer exposures to PbONP increased levels of 8-OHdG in the lung and temporarily increased lung weight after 2 and 5 weeks of exposure. The histopathological changes observed mainly in the lung and liver indicated inflammation and general toxicity responses. The present long-term inhalation study indicates risks of PbONP to both human health and the environment.
Faculty of Medicine Department of Histology and Embryology Masaryk University Brno Czech Republic
Faculty of Science RECETOX Masaryk University Brno Czech Republic
Institute of Analytical Chemistry Czech Academy of Sciences Brno Czech Republic
Institute of Animal Physiology and Genetics Czech Academy of Sciences Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20023141
- 003
- CZ-PrNML
- 005
- 20201214125342.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/17435390.2019.1685696 $2 doi
- 035 __
- $a (PubMed)31726900
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Bláhová, Lucie $u Faculty of Science, RECETOX, Masaryk University, Brno, Czech Republic.
- 245 14
- $a The effects of nano-sized PbO on biomarkers of membrane disruption and DNA damage in a sub-chronic inhalation study on mice / $c L. Bláhová, Z. Nováková, Z. Večeřa, L. Vrlíková, B. Dočekal, J. Dumková, K. Křůmal, P. Mikuška, M. Buchtová, A. Hampl, K. Hilscherová, L. Bláha,
- 520 9_
- $a Although the production of engineered nanoparticles increases our knowledge of toxicity and mechanisms of bioactivity during relevant exposures is lacking. In the present study mice were exposed to PbO nanoparticles (PbONP; 192.5 µg/m3; 1.93 × 106 particles/cm3) for 2, 5 and 13 weeks through continuous inhalation. The analyses addressed Pb and PbONP distribution in organs (lung, liver, kidney, brain) using electrothermal atomic absorption spectrometry and transmission electron microscopy, as well as histopathology and analyses of oxidative stress biomarkers. New LC-MS/MS methods were validated for biomarkers of lipid damage F2-isoprostanes (8-iso-prostaglandins F2-alpha and E2) and hydroxylated deoxoguanosine (8-OHdG, marker of DNA oxidation). Commonly studied malondialdehyde was also measured as TBARS by HPLC-DAD. The study revealed fast blood transport and distribution of Pb from the lung to the kidney and liver. A different Pb accumulation trend was observed in the brain, suggesting transfer of NP along the nasal nerve to the olfactory bulbs. Long-term inhalation of PbONP caused lipid peroxidation in animal brains (increased levels of TBARS and both isoprostanes). Membrane lipid damage was also detected in the kidney after shorter exposures, but not in the liver or lung. On the contrary, longer exposures to PbONP increased levels of 8-OHdG in the lung and temporarily increased lung weight after 2 and 5 weeks of exposure. The histopathological changes observed mainly in the lung and liver indicated inflammation and general toxicity responses. The present long-term inhalation study indicates risks of PbONP to both human health and the environment.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a mozek $x účinky léků $x metabolismus $7 D001921
- 650 12
- $a poškození DNA $7 D004249
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $7 D007249
- 650 _2
- $a inhalační expozice $x škodlivé účinky $x analýza $7 D019570
- 650 _2
- $a ledviny $x účinky léků $x metabolismus $7 D007668
- 650 _2
- $a olovo $x metabolismus $x toxicita $7 D007854
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a plíce $x účinky léků $x metabolismus $7 D008168
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové lipidy $x metabolismus $7 D008563
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední ICR $7 D008813
- 650 _2
- $a nanočástice $x metabolismus $x toxicita $7 D053758
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a oxidy $x metabolismus $x toxicita $7 D010087
- 650 _2
- $a testy subchronické toxicity $7 D059550
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nováková, Zuzana $u Faculty of Science, RECETOX, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Večeřa, Zbyněk $u Institute of Analytical Chemistry, Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Vrlíková, Lucie $u Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Dočekal, Bohumil $u Institute of Analytical Chemistry, Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Dumková, Jana $u Faculty of Medicine, Department of Histology and Embryology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Křůmal, Kamil $u Institute of Analytical Chemistry, Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Mikuška, Pavel $u Institute of Analytical Chemistry, Czech Academy of Sciences, Brno, Czech Republic.
- 700 1_
- $a Buchtová, Marcela $u Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic. Faculty of Science, Institute of Experimental Biology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Hampl, Aleš $u Faculty of Medicine, Department of Histology and Embryology, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Hilscherová, Klára $u Faculty of Science, RECETOX, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Bláha, Luděk $u Faculty of Science, RECETOX, Masaryk University, Brno, Czech Republic.
- 773 0_
- $w MED00192827 $t Nanotoxicology $x 1743-5404 $g Roč. 14, č. 2 (2020), s. 214-231
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31726900 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201214125342 $b ABA008
- 999 __
- $a ok $b bmc $g 1595460 $s 1113817
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 14 $c 2 $d 214-231 $e 20191115 $i 1743-5404 $m Nanotoxicology $n Nanotoxicology $x MED00192827
- LZP __
- $a Pubmed-20201125